Company intelligence / Profile preview

XXIV

Greenville, South Carolina, United States
Ownership
Private
Development stage
Other
01

Overview

XXIV is a science-driven skincare and longevity company focused on addressing the root causes of skin aging through mitochondrial health. The company's flagship brand, twentyfour skincare, utilizes patented sustained-release technologies to deliver active ingredients continuously over a 24-hour period. Its core products, StepZero and HYDRÍQ, incorporate the Z-pod delivery system and the AI-discovered active ingredient Y100, which is derived from the amla tree and specifically targets mitochondrial function. XXIV aims to redefine the anti-aging market by moving beyond superficial treatments to cellular-level rejuvenation with clinically proven efficacy that significantly outperforms traditional ingredients like retinol.

Therapeutic areas
Rare DiseasesDermatology
Modalities
Small moleculeTopical delivery systemNanoparticle
Industry
Non-Drug Biotech
02

Partnerships

Zylö TherapeuticsYuvaBio

Beyond the preview

Go deeper on XXIV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XXIV.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call